FilingSEC EDGAR6-K
Optimi Health Completes Production of Psilocybin Capsules for Clinical and Commercial Use
· SEC accepted
StagePhase 2
Filing content
Optimi Health announced the completion of a production batch of psilocybin capsules to supply its Health Canada-approved clinical trial and commercial customers in Australia.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…